Latest News in the pharma Industry

Biopharma News

ChargePoint assists CDMO to ensure sterility of its drug substance mixing process

31 Mar 2020

The company's aseptic split butterfly valve — AseptiSafe Bio Transfer Valve — selected to prevent product contamination and expensive product loss.

Alvotech and DKSH partner to bring key biosimilar to Asia

24 Mar 2020

Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide.

ProBioGen selected for development and large-scale manufacturing services

24 Mar 2020

The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.

Codexis and Takeda collaborate to advance novel gene therapies

23 Mar 2020

Partnership to leverage Codexis’ protein engineering platform for the discovery and development of novel transgenes for lysosomal storage disorders and blood factor deficiencies.

Lonza's new medium boosts and optimizes AAV production in insect cells

23 Mar 2020

The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.

FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

19 Mar 2020

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Oxford Biomedica signs LSA with Juno Therapeutics

19 Mar 2020

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

Vaxxas HD-MAP to deliver vaccines directly to the skin

17 Mar 2020

Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.

Sartorius simplifies biologics production with new bioreactor

9 Mar 2020

Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.

Thermo Fisher Scientific to acquire Qiagen

3 Mar 2020

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

Potential first-in-class treatment reaches significant milestone

2 Mar 2020

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

Trump and pharma execs to discuss progress on COVID-19 cure